| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/15/2005 | EP1539754A2 Benzimidazole quinolinones and uses thereof |
| 06/15/2005 | EP1539746A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 06/15/2005 | EP1539745A1 N-aryl-2-oxazolidinones and their derivatives |
| 06/15/2005 | EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/15/2005 | EP1539733A2 Azabicyclic compounds are central nervous system active agents |
| 06/15/2005 | EP1539721A1 Dibenzoxazepine |
| 06/15/2005 | EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives |
| 06/15/2005 | EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 06/15/2005 | EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 06/15/2005 | EP1539710A1 Heterocyclic derivatives |
| 06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539178A2 Protease inhibitors |
| 06/15/2005 | EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539159A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 06/15/2005 | EP1539150A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 06/15/2005 | EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 06/15/2005 | EP1539136A2 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 06/15/2005 | EP1450808B1 Quinazoline derivatives for the treatment of t cell mediated diseases |
| 06/15/2005 | EP1349856B1 Isoindolin-1-one glucokinase activators |
| 06/15/2005 | EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/15/2005 | EP1255754B1 Linezolid-crystal form ii |
| 06/15/2005 | EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 06/15/2005 | EP1104412B1 Tace inhibitors |
| 06/15/2005 | EP1048658B1 Alicyclic acylated heterocyclic derivatives |
| 06/15/2005 | EP1020451B1 Anilide compounds and drugs containing the same |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | CN1628114A Coumarines useful as biomarkers |
| 06/15/2005 | CN1628100A Gamma secretase inhibitors |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1626527A Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative |
| 06/15/2005 | CN1626521A Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/14/2005 | US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 06/14/2005 | US6906104 Aminediols for the treatment of Alzheimer's disease |
| 06/14/2005 | US6906095 Central nervous system disorders; anxiolytic agents; antidepressants; muscular disorders |
| 06/14/2005 | US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906070 Anticoagulants |
| 06/14/2005 | US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/14/2005 | US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/14/2005 | CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 06/09/2005 | WO2005051945A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treatment and/or prevention of disorders modulated by a ppar |
| 06/09/2005 | WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide |
| 06/09/2005 | WO2005051931A2 Phosphodiesterase inhibitors |
| 06/09/2005 | WO2005051923A1 Quinazoline derivatives |
| 06/09/2005 | WO2005051918A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds |
| 06/09/2005 | WO2005051913A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051398A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 06/09/2005 | WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) |
| 06/09/2005 | WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/09/2005 | WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/09/2005 | WO2005028475A3 Compositions useful as inhibitors of protein kinases |
| 06/09/2005 | WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124670 Novel arylazole derivatives, their manufacture and use as pharmaceutical agents |
| 06/09/2005 | US20050124661 Inhibitors of peroxisome proliferation, enzyme inhibitors to treat obesity and other diseases |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124627 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide |
| 06/09/2005 | US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders |
| 06/09/2005 | US20050124619 Medical devices employing triazine compounds and compositions thereof |
| 06/09/2005 | US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy |
| 06/09/2005 | US20050124611 Such as N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]-4-morpholineacetamide; potassium channel modulators |
| 06/09/2005 | US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124562 Using Dna polymerase inhibitor as bactericide |
| 06/09/2005 | US20050124497 Pesticide, 5-tert-butyl-2-{4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]phenyl}-1,3-benzoxazole; chemical intermediates, N-(5-tert-butyl-2-hydroxyphenyl)-4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]benzamide; applying on plants, animals |
| 06/09/2005 | US20050124209 Illuminated electrical cords and outlets |
| 06/09/2005 | DE10353910A1 Verfahren zur Synthese optisch aktiver Piperidine Process for the synthesis of optically active piperidines |
| 06/09/2005 | CA2547472A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545659A1 Bicyclic inhibitors of mek |
| 06/09/2005 | CA2545601A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | CA2545262A1 Quinazoline derivatives |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537111A1 Hetereoaryl nitrile derivatives |
| 06/08/2005 | EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 06/08/2005 | EP1537099A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 06/08/2005 | EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |